{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:00:40Z","timestamp":1779256840055,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Neurofibromatosis type 1 (NF1) is characterized by an extreme clinical variability both within and between families that cannot be explained solely by the nature of the pathogenic <jats:italic>NF1<\/jats:italic> gene mutations. A proposed model hypothesizes that variation in the levels of protein isoforms generated via alternative transcript processing acts as modifier and contributes to phenotypic variability.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Here we used real-time quantitative PCR to investigate the levels of two major <jats:italic>NF1<\/jats:italic> mRNA isoforms encoding proteins differing in their ability to control RAS signaling (isoforms I and II) in the peripheral blood leukocytes of 138 clinically well-characterized NF1 patients and 138 aged-matched healthy controls. As expected, expression analysis showed that <jats:italic>NF1<\/jats:italic> isoforms I and II levels were significantly lower in patients than controls. Notably, these differences were more evident when patients were stratified according to the severity of phenotype. Moreover, a correlation was identified when comparing the levels of isoform I mRNA and the severity of NF1 features, with statistically significant lower levels associated with a severe phenotype (i.e., occurrence of learning disability\/intellectual disability, optic gliomas and\/or other neoplasias, and\/or cerebrovascular disease) as well as in patients with cognitive impairment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The present findings provide preliminary evidence for a role of circuits controlling <jats:italic>NF1<\/jats:italic> transcript processing in modulating NF1 expressivity, and document an association between the levels of neurofibromin isoform I mRNA and the severity of phenotype and cognitive impairment in NF1.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13023-019-1223-1","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T17:02:47Z","timestamp":1573837367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1"],"prefix":"10.1186","volume":"14","author":[{"given":"Antonia","family":"Assunto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annapina","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Giovanna","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9458-3926","authenticated-orcid":false,"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"issue":"12","key":"1223_CR1","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/cdd.2016.91","volume":"23","author":"MP Paronetto","year":"2016","unstructured":"Paronetto MP, Passacantilli I, Sette C. Alternative splicing and cell survival: from tissue homeostasis to disease. Cell Death Differ. 2016;23(12):1919\u201329.","journal-title":"Cell Death Differ"},{"key":"1223_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2016.01.010","volume":"109","author":"T Iijima","year":"2016","unstructured":"Iijima T, Hidaka C, Iijima Y. Spatio-temporal regulations and functions of neuronal alternative RNA splicing in developing and adult brains. Neurosci Res. 2016;109:1\u20138.","journal-title":"Neurosci Res"},{"issue":"2","key":"1223_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.hdy.6800904","volume":"100","author":"JH Marden","year":"2008","unstructured":"Marden JH. Quantitative and evolutionary biology of alternative splicing: how changing the mix of alternative transcripts affects phenotypic plasticity and reaction norms. Heredity. 2008;100(2):111\u201320.","journal-title":"Heredity"},{"issue":"12","key":"1223_CR4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/ng.259","volume":"40","author":"Q Pan","year":"2008","unstructured":"Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413\u20135. https:\/\/doi.org\/10.1038\/ng.259 Epub 2008 Nov 2.","journal-title":"Nat Genet"},{"issue":"10","key":"1223_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrg2164","volume":"8","author":"GS Wang","year":"2007","unstructured":"Wang GS, Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet. 2007;8(10):749\u201361 Epub 2007 Aug 29.Review.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"1223_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1042\/BSR20110060","volume":"32","author":"VA Barron","year":"2012","unstructured":"Barron VA, Lou H. Alternative splicing of the neurofibromatosis type I pre-mRNA. Biosci Rep. 2012;32(2):131\u20138. https:\/\/doi.org\/10.1042\/BSR20110060 Review.","journal-title":"Biosci Rep"},{"key":"1223_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A:327\u201332.","journal-title":"Am J Med Genet A"},{"key":"1223_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/jid.2014.465","volume":"135","author":"E Uusitalo","year":"2015","unstructured":"Uusitalo E, Leppavirta J, Koffert A, et al. Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol. 2015;135:904\u20136.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1223_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","volume":"70","author":"AB Trov\u00f3-Marqui","year":"2006","unstructured":"Trov\u00f3-Marqui AB, Tajara EH. Neurofibromin: a general outlook. Clin Genet. 2006;70(1):1\u201313.","journal-title":"Clin Genet"},{"key":"1223_CR10","first-page":"17","volume-title":"Molecular and cellular biology","author":"S Peltonen","year":"2012","unstructured":"Peltonen, S., And Po\u00a8yho\u00a8nen M. Clinical diagnosis and atypical forms of NF1. In M. Upadhyaya and D.N. Cooper, eds. Molecular and cellular biology, Springer-Verlag Berlin, 2012. pp. 17\u201330."},{"issue":"8","key":"1223_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/jmedgenet-2012-100978","volume":"49","author":"E Pasmant","year":"2012","unstructured":"Pasmant E, Vidaud M, Vidaud D, Wolkenstein P. Neurofibromatosis type 1: from genotype to phenotype. J Med Genet. 2012 Aug;49(8):483\u20139. https:\/\/doi.org\/10.1136\/jmedgenet-2012-100978.","journal-title":"J Med Genet"},{"issue":"6","key":"1223_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/humu.9245","volume":"23","author":"A De Luca","year":"2004","unstructured":"De Luca A, Schirinzi A, Buccino A, Bottillo I, Sinibaldi L, Torrente I, Ciavarella A, Dottorini T, Porciello R, Giustini S, Calvieri S, Dallapiccola B. Novel and recurrent mutations in the NF1 gene in Italian patients with neurofibromatosis type 1. Hum Mutat. 2004 Jun;23(6):629.","journal-title":"Hum Mutat"},{"key":"1223_CR13","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.22392","volume":"34","author":"A Sabbagh","year":"2013","unstructured":"Sabbagh A, Pasmant E, Imbard A, et al. NF1 molecular characterization and neurofi- bromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34:1510\u20138.","journal-title":"Hum Mutat"},{"issue":"4","key":"1223_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136(4):349\u201376. https:\/\/doi.org\/10.1007\/s00439-017-1766-y Epub 2017 Feb 17.","journal-title":"Hum Genet"},{"key":"1223_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M, Chen Y, Callens T, et al. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844\u2013848. Am J Hum Genet. 2018;102:69\u201387.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"1223_CR16","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/ejhg.2014.243","volume":"23","author":"V Pinna","year":"2015","unstructured":"Pinna V, Lanari V, Daniele P, Consoli F, Agolini E, Margiotti K, Bottillo I, Torrente I, Bruselles A, Fusilli C, Ficcadenti A, Bargiacchi S, Trevisson E, Forzan M, Giustini S, Leoni C, Zampino G, Digilio MC, Dallapiccola B, Clementi M, Tartaglia M, De Luca A. P.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet. 2015;23(8):1068\u201371. https:\/\/doi.org\/10.1038\/ejhg.2014.243 Epub 2014 Nov 5.","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"1223_CR17","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/humu.22832","volume":"36","author":"K Rojnueangnit","year":"2015","unstructured":"Rojnueangnit K, Xie J, Gomes A, Sharp A, Callens T, Chen Y, Liu Y, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat. 2015;36(11):1052\u201363. https:\/\/doi.org\/10.1002\/humu.22832 Epub 2015 Aug 21.","journal-title":"Hum Mutat"},{"issue":"1","key":"1223_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1086\/510781","volume":"80","author":"M Upadhyaya","year":"2007","unstructured":"Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L. An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970\u20132972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet. 2007;80(1):140\u201351 Epub 2006 Dec 8.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1223_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","volume":"21","author":"M Koczkowska","year":"2019","unstructured":"Koczkowska M, Callens T, Gomes A, et al. Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet Med. 2019;21(4):867\u201376. https:\/\/doi.org\/10.1038\/s41436-018-0269-0 Epub 2018 Sep 7.","journal-title":"Genet Med"},{"issue":"2","key":"1223_CR20","first-page":"305","volume":"53","author":"DF Easton","year":"1993","unstructured":"Easton DF, Ponder MA, Huson SM, Ponder BA. An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet. 1993 Aug;53(2):305\u201313.","journal-title":"Am J Hum Genet"},{"key":"1223_CR21","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/ddp212","volume":"18","author":"A Sabbagh","year":"2009","unstructured":"Sabbagh A, Pasmant E, Laurendeau I, et al. members of the NF France Network . Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet. 2009;18:2768\u201378.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1223_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/79075","volume":"26","author":"KM Reilly","year":"2000","unstructured":"Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat Genet. 2000 Sep;26(1):109\u201313.","journal-title":"Nat Genet"},{"issue":"35","key":"1223_CR23","doi-asserted-by":"publisher","first-page":"13008","DOI":"10.1073\/pnas.0401236101","volume":"101","author":"KM Reilly","year":"2004","unstructured":"Reilly KM, Tuskan RG, Christy E, Loisel DA, Ledger J, Bronson RT, Smith CD, Tsang S, Munroe DJ, Jacks T. Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Proc Natl Acad Sci U S A. 2004;101(35):13008\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1223_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/86898","volume":"27","author":"RM Costa","year":"2001","unstructured":"Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet. 2001;27(4):399\u2013405.","journal-title":"Nat Genet"},{"issue":"6871","key":"1223_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature711","volume":"415","author":"RM Costa","year":"2002","unstructured":"Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 2002;415(6871):526\u201330 Epub 2002 Jan 16.","journal-title":"Nature"},{"key":"1223_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10048-006-0078-5","volume":"8","author":"JJ Hawes","year":"2007","unstructured":"Hawes JJ, Tuskan RG, Reilly KM. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Neurogenetics. 2007;8:121\u201330.","journal-title":"Neurogenetics"},{"issue":"1","key":"1223_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0006-291X(05)81497-4","volume":"187","author":"T Uchida","year":"1992","unstructured":"Uchida T, Matozaki T, Suzuki T, Matsuda K, Wada K, Nakano O, Konda Y, Nishisaki H, Nagao M, Sakamoto C, et al. Expression of two types of neurofibromatosis type 1 gene transcripts in gastric cancers and comparison of GAP activities. Biochem Biophys Res Commun. 1992;187(1):332\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1223_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/MCB.13.1.487","volume":"13","author":"LB Andersen","year":"1993","unstructured":"Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol. 1993 Jan;13(1):487\u201395.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1223_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0147-0272(82)80016-0","volume":"7","author":"VM Riccardi","year":"1982","unstructured":"Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer. 1982;7(2):1\u201334.","journal-title":"Curr Probl Cancer"},{"issue":"9","key":"1223_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"1223_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"LM Messiaen","year":"2000","unstructured":"Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van Roy N, Speleman F, Paepe AD. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541\u201355.","journal-title":"Hum Mutat"},{"issue":"11","key":"1223_CR32","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/humu.20396","volume":"27","author":"E Pros","year":"2006","unstructured":"Pros E, Larriba S, L\u00f3pez E, Ravella A, Gili ML, Kruyer H, Valls J, Serra E, L\u00e1zaro C. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing. Hum Mutat. 2006 Nov;27(11):1104\u201314.","journal-title":"Hum Mutat"},{"issue":"1","key":"1223_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/MCB.13.1.487","volume":"13","author":"LB Andersen","year":"1993","unstructured":"Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol. 1993 Jan;13(1):487\u201395.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"1223_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1086\/519562","volume":"81","author":"O Maertens","year":"2007","unstructured":"Maertens O, De Schepper S, Vandesompele J, Brems H, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet. 2007;81(2):243\u201351 Epub 2007 Jun 20.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1223_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1086\/504441","volume":"79","author":"DA Stevenson","year":"2006","unstructured":"Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D'Astous JL, Santora SD, Viskochil DH. Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet. 2006;79(1):143\u20138 Epub 2006 May 10.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"1223_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/jmedgenet-2014-102815","volume":"52","author":"DW Sant","year":"2015","unstructured":"Sant DW, Margraf RL, Stevenson DA, Grossmann AH, Viskochil DH, Hanson H, Everitt MD, Rios JJ, Elefteriou F, Hennessey T, Mao R. Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1. J Med Genet. 2015;52(4):256\u201361. https:\/\/doi.org\/10.1136\/jmedgenet-2014-102815 Epub 2015 Jan 22.","journal-title":"J Med Genet"},{"key":"1223_CR37","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017 Feb 23;3:17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4.","journal-title":"Nat Rev Dis Primers"},{"key":"1223_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mcn.2017.10.006","volume":"87","author":"RS Porter","year":"2018","unstructured":"Porter RS, Jaamour F, Iwase S. Neuron-specific alternative splicing of transcriptional machineries: implications. For neurodevelopmental disorders. Mol Cell Neurosci. 2018 Mar;87:35\u201345. https:\/\/doi.org\/10.1016\/j.mcn.2017.10.006.","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"1223_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1073858416678604","volume":"23","author":"E Lara-Pezzi","year":"2017","unstructured":"Lara-Pezzi E, Desco M, Gatto A, G\u00f3mez-Gaviro MV. Neurogenesis: regulation by alternative splicing and related posttranscriptional processes. Neuroscientist. 2017 Oct;23(5):466\u201377. https:\/\/doi.org\/10.1177\/1073858416678604.","journal-title":"Neuroscientist"},{"key":"1223_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2017.09.018)","volume":"75","author":"X Song","year":"2018","unstructured":"Song X, Zeng Z, Wei H, Wang Z. Alternative splicing in cancers: from aberrant regulation to new therapeutics. Semin Cell Dev Biol. 2018;75:13\u201322. https:\/\/doi.org\/10.1016\/j.semcdb.2017.09.018).","journal-title":"Semin Cell Dev Biol"},{"key":"1223_CR41","doi-asserted-by":"publisher","unstructured":"Perrone B, La Cognata V, Sprovieri T, Ungaro C, Conforti FL, And\u00f2 S, Cavallaro S. Alternative splicing of ALS genes: Misregulation and potential therapies. Mol Neurobiol. 2019 Aug 5. https:\/\/doi.org\/10.1007\/s10571-019-00717-0.","DOI":"10.1007\/s10571-019-00717-0"},{"key":"1223_CR42","doi-asserted-by":"crossref","unstructured":"Black AJ, Gamarra JR, Giudice J. More than a messenger: Alternative splicing as a therapeutic target. Biochim Biophys Acta Gene Regul Mech. 2019.","DOI":"10.1016\/j.bbagrm.2019.06.006"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1223-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1223-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:13:58Z","timestamp":1605312838000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1223-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1223-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"8 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study was approved by Ethics Committee with comunication number 1893\/18, study protocol number 315\/18 \u201cComitato Etico Universit\u00e0 Federico II di Napoli, Prof Claudio Buccelli\u201d.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Manuscript does not include use of any animal or human data or tissue and does not contain data from any individual person.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict. The authors declare that they have no competing interests\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}